Skip to content

The Evaluation in usefulness of Guiding Marker SystemTM and magnetic probe, for detecting and resecting of non-palpable lesions of the breast

The Evaluation in usefulness of Guiding Marker SystemTM and magnetic probe, for detecting and resecting of non-palpable lesions of the breast - The Evaluation of magnetic probe system for detecting of non-palpable lesions of the breast

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032180422
Enrollment
33
Registered
2019-03-25
Start date
2019-01-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Sponsors

Takeo Hiroyuki
Lead Sponsor
Kusakabe Moriaki
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Non-palpable breast cancer or non-palpable lesion suspected breast cancer which is planed surgical procedure. 2.Over 20 years old when its consented 3.Written informed consent

Exclusion criteria

Exclusion criteria: 1.Metal allergy 2.Patient who had breast implant insertion surgery 3.Breast cancer patient in pregnancy period or lactation period 4.Male breast cancer 5.Inflammatory breast cancer 6.Patient who is assessed not applicable by physicians

Design outcomes

Primary

MeasureTime frame
Complete resection of guiding marker

Secondary

MeasureTime frame
Positive rate of the surgical margin Re-operation / boost radiation within 3 months after breast conserving surgery Safety

Contacts

Public ContactTomoko Kurita

Nippon Medical School Hospital

tomoko28@nms.ac.jp+81-3-3822-2131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026